3.33. Analysis.
Comparison 3 COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE, Outcome 33 Cost effectiveness analysis (high=poor, data skewed).
Cost effectiveness analysis (high=poor, data skewed) | |||||
---|---|---|---|---|---|
Study | Intervention | Mean | SD | N | Note |
Cost of hospitalisation (in RMB) | |||||
Liu 2010 | Aripiprazole | 3413.66 | 1815.05 | 30 | |
Liu 2010 | Risperidone | 4551.41 | 3024.38 | 54 | |
Cost of drug (in RMB) | |||||
Liu 2010 | Aripiprazole | 418.13 | 326.43 | 30 | |
Liu 2010 | Risperidone | 685.00 | 493.02 | 54 | |
Length of hospitalisation (day) | |||||
Liu 2010 | Aripiprazole | 33.19 | 16.71 | 30 | |
Liu 2010 | Risperidone | 50.84 | 40.85 | 28 |